Early preclinical work with gonadotropin-releasing hormone analogues

In this article, I provide a narrative remembrance of the many early proof-of-concept studies that were performed at the Jones Institute for Reproductive Medicine in the late 1980s and early 1990s. A group, led by the late Dr. Gary Hodgen, piloted some of the ways gonadotropin-releasing hormone anal...

Full description

Bibliographic Details
Main Author: Keith Gordon, Ph.D.
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:F&S Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666334123000090
_version_ 1797829078472982528
author Keith Gordon, Ph.D.
author_facet Keith Gordon, Ph.D.
author_sort Keith Gordon, Ph.D.
collection DOAJ
description In this article, I provide a narrative remembrance of the many early proof-of-concept studies that were performed at the Jones Institute for Reproductive Medicine in the late 1980s and early 1990s. A group, led by the late Dr. Gary Hodgen, piloted some of the ways gonadotropin-releasing hormone analogues are now being used clinically. We also put many different early peptide and small molecule (orally active) gonadotropin-releasing hormone antagonists through a battery of tests to explore their effects on male and female reproductive hormones. Most of the compounds we tested never reached the clinic because of various reasons. However, some have and are now making a difference in people’s lives.
first_indexed 2024-04-09T13:14:41Z
format Article
id doaj.art-7d811206ec434d66ab9206aca54fde4c
institution Directory Open Access Journal
issn 2666-3341
language English
last_indexed 2024-04-09T13:14:41Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series F&S Reports
spelling doaj.art-7d811206ec434d66ab9206aca54fde4c2023-05-12T04:17:14ZengElsevierF&S Reports2666-33412023-06-01425155Early preclinical work with gonadotropin-releasing hormone analoguesKeith Gordon, Ph.D.0Reprint requests: Keith Gordon, Ph.D., Organon Inc, 1180 Church Road, Lansdale, Pennsylvania 19446.; Global Medical Affairs, Organon Inc, Lansdale, PennsylvaniaIn this article, I provide a narrative remembrance of the many early proof-of-concept studies that were performed at the Jones Institute for Reproductive Medicine in the late 1980s and early 1990s. A group, led by the late Dr. Gary Hodgen, piloted some of the ways gonadotropin-releasing hormone analogues are now being used clinically. We also put many different early peptide and small molecule (orally active) gonadotropin-releasing hormone antagonists through a battery of tests to explore their effects on male and female reproductive hormones. Most of the compounds we tested never reached the clinic because of various reasons. However, some have and are now making a difference in people’s lives.http://www.sciencedirect.com/science/article/pii/S2666334123000090Nonhuman primate modelsproof-of-conceptGnRH analoguespreclinical
spellingShingle Keith Gordon, Ph.D.
Early preclinical work with gonadotropin-releasing hormone analogues
F&S Reports
Nonhuman primate models
proof-of-concept
GnRH analogues
preclinical
title Early preclinical work with gonadotropin-releasing hormone analogues
title_full Early preclinical work with gonadotropin-releasing hormone analogues
title_fullStr Early preclinical work with gonadotropin-releasing hormone analogues
title_full_unstemmed Early preclinical work with gonadotropin-releasing hormone analogues
title_short Early preclinical work with gonadotropin-releasing hormone analogues
title_sort early preclinical work with gonadotropin releasing hormone analogues
topic Nonhuman primate models
proof-of-concept
GnRH analogues
preclinical
url http://www.sciencedirect.com/science/article/pii/S2666334123000090
work_keys_str_mv AT keithgordonphd earlypreclinicalworkwithgonadotropinreleasinghormoneanalogues